Indrayani Biotech Ltd Q4 FY2022 consolidated PAT up at Rs. 1.60 crore

INDRAYANI BIOTECH LTD. has reported Consolidated financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 17.2521 crores during the period ended March 31, 2022 as compared to Rs. 15.4035 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 1.6089 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 1.1453 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 0.47 for the period ended March 31, 2022 as compared to Rs. 0.33 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 17.2521 crs	₹15.4035 crs	12.00%
Net Profit	₹1.6089 crs	₹1.1453 crs	40.48%
EPS	₹0.47	₹0.33	42.42%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 17.2521 crores during the period ended March 31, 2022 as compared to Rs.7.3115 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.1.6089 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-3.2466 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.0.47 for the period ended March 31, 2022 as compared to Rs.-0.92 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 17.2521 crs	₹7.3115 crs	135.96%
Net Profit	₹1.6089 crs	₹-3.2466 crs	149.56%
EPS	₹0.47	₹-0.92	151.09%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.61.7926 crores during the Financial Year ended March 31, 2022 as compared to Rs.21.3534 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.4.4395 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-11.2144 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.1.30 for the Financial Year ended March 31, 2022 as compared to Rs.-3.15 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹61.7926 crs	₹21.3534 crs	189.38%
Net Profit	₹4.4395 crs	₹-11.2144 crs	139.59%
EPS	₹1.30	₹-3.15	141.27%

Shares of INDRAYANI BIOTECH LTD. was last trading in BSE at Rs. 39.05 as compared to the previous close of Rs. 39.15. The total number of shares traded during the day was 27433 in over 268 trades.

The stock hit an intraday high of Rs. 40.00 and intraday low of 37.25. The net turnover during the day was Rs. 1067310.00.

Source : Equity Bulls

Keywords

IndrayaniBiotech Q4FY22 FY2022 ResultUpdate